PureTech Makes Senior Appointments
PureTech Health PLC, has appointed Jeff Stevens vice president of growth strategy and operations and added Feng Zhang to its scientific advisory board (SAB). PureTech has also expanded its team of senior advisors to include Meghan Fitzgerald, executive vice president of corporate strategy, M&A and health policy at Cardinal Health; Atul Pande, former senior vice president and head of neurosciences at GlaxoSmithKline PLC and Philip J. Larsen, global head of diabetes research & development at Sanofi.
You may also be interested in...
Swiss biotech Molecular Partners will receive upfront payment of CHF 60m, including equity.
Combination of antibody therapy and Gilead's Veklury fails to show potential in patients with advanced disease.
Coronavirus Update: AstraZeneca’s Vaccine Trials Cleared To Restart In the US, J&J Prepares To Restart Its Vaccine Study
Two potential COVID-19 vaccine trials from AstraZeneca and Johnson & Johnson are set to resume in the US following temporary pauses due to safety concerns. Data from both could come later this year.